scholarly journals Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis

The Breast ◽  
2021 ◽  
Vol 57 ◽  
pp. 5-17
Author(s):  
Elizabeth M. Salvo ◽  
Abril Oliva Ramirez ◽  
Jenilee Cueto ◽  
Ernest H. Law ◽  
Aaron Situ ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Endocrine Therapy ◽  
Early Breast Cancer ◽  
Meta Analysis ◽  
Adjuvant Endocrine Therapy ◽  
Risk Of Recurrence

Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials

2017 ◽  
Vol 34 (7) ◽  
Author(s):  
Ezzeldin M. Ibrahim ◽  
Marwan R. Al-Hajeili ◽  
Ali M. Bayer ◽  
Omalkhair A. Abulkhair ◽  
Ahmed A. Refae
Keyword(s):  
Breast Cancer ◽  
Endocrine Therapy ◽  
Early Breast Cancer ◽  
Randomized Trials ◽  
Meta Analysis ◽  
Adjuvant Endocrine Therapy

scholarly journals Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis

ESMO Open ◽  
2021 ◽  
Vol 6 (2) ◽  
pp. 100088
Author(s):  
S. Peleg Hasson ◽  
M.R. Brezis ◽  
E. Shachar ◽  
S.S. Shachar ◽  
I. Wolf ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Cancer Patients ◽  
Endocrine Therapy ◽  
Meta Analysis ◽  
Adjuvant Endocrine Therapy ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis

2020 ◽  
Vol 76 (9) ◽  
pp. 1199-1211
Author(s):  
Susanna M. Wallerstedt ◽  
Astrid Nilsson Ek ◽  
Roger Olofsson Bagge ◽  
Anikó Kovács ◽  
Annika Strandell ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Early Breast Cancer ◽  
Meta Analysis ◽  
Personalised Medicine ◽  
Intermediate Risk ◽  
Risk Of Recurrence
Sign in / Sign up

Export Citation Format

Share Document